Oak Bay Biosciences is a biotechnology company that works on developing next-generation therapies for inherited retinal diseases.
Oak Bay Biosciences has raised $250K in total funding. The most recent round was Seed. The last funding was announced in May 2022.
Oak Bay Biosciences's investors include Newchip Accelerator.
Oak Bay Biosciences is headquartered in Victoria, Canada.
Oak Bay Biosciences is a biotechnology company that works on developing next-generation therapies for inherited retinal diseases.
Oak Bay Biosciences is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Oak Bay Biosciences — Funding & Investors." VCBacked, May 10, 2022, https://www.vcbacked.co/company/oak-bay-biosciences. Accessed October 28, 2026.
VCBacked. (2022). Oak Bay Biosciences — Funding & Investors. Retrieved October 28, 2026, from https://www.vcbacked.co/company/oak-bay-biosciences
{{cite web |title=Oak Bay Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/oak-bay-biosciences |website=VCBacked |access-date=October 28, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated